Surgeon general nominee postpones confirmation hearing due to unexpected labor, prolonging vacancy in top public health post.
Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
Deadly protest in Jerusalem as ultra-Orthodox Jews rally against military draft plans
Surgeon general nominee postpones confirmation hearing due to unexpected labor, prolonging vacancy in top public health post.
Novo Nordisk launches a $56.50 per share bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and highlighting the strategic value of Metsera's GLP-1 pipeline.
Deadly protest in Jerusalem as ultra-Orthodox Jews rally against military draft plans